Market Overview

Catamaran's BriovaRx Awarded Specialty Pharmacy Accreditation from URAC

Catamaran Corp. (NASDAQ: CTRX) has been awarded
Specialty Pharmacy Accreditation from URAC, a Washington, D.C.-based accrediting organization that
establishes quality standards for the healthcare industry.

"BriovaRx's robust offerings focus on the patient, ensuring one-on-one
support and a personalized plan that addresses chronic conditions to
help them lead healthy, vibrant lives," said Mark Thierer, Chairman and
CEO of Catamaran. "The URAC accreditation is a reflection of BriovaRx's
patient-centric approach that coordinates the efforts of providers,
payers and manufacturers to keep treatments personalized and
successful."

Designed as a better alternative to other specialty pharmacy offerings,
BriovaRx is a high-touch, comprehensive care system of pharmacological
care where patients with chronic illnesses and complex diseases receive
expert therapy management and support tailored to their individual
needs.

URAC made the decision to develop a Specialty Pharmacy accreditation
program because it is one of the key distribution channels for pharmacy
benefit management and extends URAC's consumer protection and
empowerment efforts in managed care pharmacy. URAC offers the only
third-party, voluntary accreditation program of this scope for pharmacy
benefit management and prescription services

See full press release

Posted-In: News Guidance Contracts Management Global

 

Most Popular

Related Articles (CTRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free